生命理工医療科学専攻・医用器材学講座

19  件  
※ 登録方法の違いにより重複して表示されている場合があります。

  1. Takahiro Kozawa, Rito Fujiwara, Kayo Fukuyama, Kanako Yoshida, Soichiro Usuki, Masakazu Kawashita, Kota Hoshino, Satoshi Ota, Hiroya Abe: Magnetic Macroporous Microspheres from FeCO3 via Water Vapor-Mediated Thermal Decomposition: Implications for Nanoparticle Capture and Biomedical Applications ACS Applied Nano Materials. 2025.09; 8 18781-18789. ( DOI )

  2. Peng Chen, Soichiro Usuki, Karen Kuroyama, Tomoyo Goto, Tohru Sekino, Hiroyasu Kanetaka, Tomoka Hasegawa, Masakazu Kawashita, Tetsuya Yoda, Taishi Yokoi: Physicochemical properties and cellular compatibility of calcium phosphate/pyrolytic carbon composites for artificial bone applications Journal of Asian Ceramic Societies. 2025.08; 1-8. ( DOI )

  3. Development of a sensor‑compatible vascular microphysiological system for metabolic monitoring during drug‑induced endothelial injury 2025.07;

  4. Usuki S, Ogawa T, Shimabukuro M, Yokoi T, Kawashita M: Synthesis of ε-Fe#D2-3#DRN Particles for Magnetic Hyperthermia. Journal of functional biomaterials. 2025.06; 16 (6): ( PubMed , DOI )

  5. Suzuki, Y; Usuki, S; Nishizawa, M; Tanaka, N; Suhara, Y; Yajima, I: Acyclic Retinoid Overcomes Vemurafenib Resistance in Melanoma Cells via Dual Inhibition of MAPK and PI3K/AKT/mTOR Pathways ANTICANCER RESEARCH. 2025.06; 45 (6): 2265-2278. ( PubMed , DOI )

  6. Kobayakawa T, Arioka M, Yamamoto K, Tsuji K, Tamamura H: Diastereoselective synthesis of (Z)-fluoroalkene dipeptide isosteres utilizing chiral auxiliaries Org Biomol Chem. 2025.05; 23 (18): 4333-4336. ( PubMed , DOI )

  7. Takuya Kobayakawa, Kenichi Yamamoto, Aiichiro Fukutome, Marisa Arioka, Kohei Tsuji, Hirokazu Tamamura: Design and synthesis of a C2-symmetric cyclic decapeptide and its peptidomimetic as potential inhibitors against amyloid-beta aggregation. SYNLETT. 2025.04; 36 (17): 2948-2952. ( DOI )

  8. Toshiki Miyazaki, Juna Miyamoto, Jin Nakamura, Soichiro Usuki, Taishi Yokoi, Masakazu Kawashita: Magnetic Properties, Heat Generation, and Apatite Formation Ability of Mg‐Ti Ferrite Particles Synthesized by Solid‐State Reaction and Polymerized Complex Methods Advanced Engineering Materials. 2025.02; 27 (4): 2401803. ( DOI )

  1. Shinohara K, Kobayakawa T, Tsuji K, Takamatsu Y, Mitsuya H, Tamamura H: Naphthalen-1-ylethanamine-containing small molecule inhibitors of the papain-like protease of SARS-CoV-2. European journal of medicinal chemistry. 2024.12; 280 116963. ( PubMed , DOI )

  2. Kobayakawa Takuya, Yokoyama Masaru, Tsuji Kohei, Boku Sayaka, Kurakami Masaki, Fujino Masayuki, Ishii Takahiro, Miura Yutaro, Nishimura Soshi, Shinohara Kouki, Yamamoto Kenichi, Bolah Peter, Kotani Osamu, Murakami Tsutomu, Sato Hironori, Tamamura Hirokazu: HIV-1カプシド蛋白質を標的とする低分子抗HIV-1薬の開発(Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins) Chemical & Pharmaceutical Bulletin. 2024.01; 72 (1): 41-47. ( 医中誌 )

  3. Kobayakawa T, Yokoyama M, Tsuji K, Boku S, Kurakami M, Fujino M, Ishii T, Miura Y, Nishimura S, Shinohara K, Yamamoto K, Bolah P, Kotani O, Murakami T, Sato H, Tamamura H: Development of Small-Molecule Anti-HIV-1 Agents Targeting HIV-1 Capsid Proteins. Chemical & pharmaceutical bulletin. 2024; 72 (1): 41-47. ( PubMed , DOI )

  1. Kohei Tsuji, Takuya Kobayakawa, Takahiro Ishii, Nobuyo Higashi-Kuwata, Chika Azuma, Kouki Shinohara, Yutaro Miura, Kenichi Yamamoto, Soshi Nishimura, Shin-ichiro Hattori, Haydar Bulut, Hiroaki Mitsuya, Hirokazu Tamamura: Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement. Chemical and Pharmaceutical Bulletin. 2023.12; 71 (12): 879-886. ( PubMed , DOI )

  2. Tsuji Kohei, Kobayakawa Takuya, Ishii Takahiro, Higashi-Kuwata Nobuyo, Azuma Chika, Shinohara Kouki, Miura Yutaro, Yamamoto Kenichi, Nishimura Soshi, Hattori Shin-ichiro, Bulut Haydar, Mitsuya Hiroaki, Tamamura Hirokazu: ハロゲン導入およびアミド結合置換によるSARS-CoV-2のメインプロテアーゼに有効な阻害薬の探索研究(Exploratory Studies of Effective Inhibitors against the SARS-CoV-2 Main Protease by Halogen Incorporation and Amide Bond Replacement) Chemical & Pharmaceutical Bulletin. 2023.12; 71 (12): 879-886. ( 医中誌 )

  3. Takuya Kobayakawa, Masayuki Amano, Miyuki Nakayama, Kohei Tsuji, Takahiro Ishii, Yutaro Miura, Kouki Shinohara, Kenichi Yamamoto, Masao Matsuoka, Hirokazu Tamamura: Development of anti-HBV agents targeting HBV capsid proteins. RSC Medicinal Chemistry. 2023.10; 14 (10): 1973-1980. ( PubMed , DOI )

  4. Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Kouki Shinohara, Chika Azuma, Yutaro Miura, Hiroki Nakano, Naoya Wada, Shin-ichiro Hattori, Haydar Bulut, Hiroaki Mitsuya, Hirokazu Tamamura: Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties. Journal of Medicinal Chemistry. 2023.10; 66 (19): 13516-13529. ( PubMed , DOI )

  5. Tsuji K, Baffour-Awuah Owusu K, Miura Y, Ishii T, Shinohara K, Kobayakawa T, Emi A, Nakano T, Suzuki Y, Tamamura H: Dimerized fusion inhibitor peptides targeting the HR1-HR2 interaction of SARS-CoV-2. RSC advances. 2023.03; 13 (13): 8779-8793. ( PubMed , DOI )

  1. Kohei Tsuji, Takahiro Ishii, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, Chika Azuma, Miyuki Nakayama, Takato Onishi, Hiroki Nakano, Naoya Wada, Miki Hori, Kouki Shinohara, Yutaro Miura, Takuma Kawada, Hironori Hayashi, Shin-Ichiro Hattori, Haydar Bulut, Debananda Das, Nobutoki Takamune, Naoki Kishimoto, Junji Saruwatari, Tadashi Okamura, Kenta Nakano, Shogo Misumi, Hiroaki Mitsuya, Hirokazu Tamamura: Potent and biostable inhibitors of the main protease of SARS-CoV-2. iScience. 2022.11; 105365. ( PubMed , DOI )

  1. 深見嘉明,米山徹朋,鳥谷真佐子: スポーツデータエコシステム紹介 経営情報学会誌. 2025.11; 34 (3): 164-165.

  1. Takuya Kobayakawa, Masaru Yokoyama, Kohei Tsuji, Masayuki Fujino, Masaki Kurakami, Takato Onishi, Sayaka Boku, Takahiro Ishii, Yutaro Miura, Kouki Shinohara, Yuki Kishihara, Nami Ohashi, Osamu Kotani, Tsutomu Murakami, Hironori Sato, Hirokazu Tamamura: Low-molecular-weight anti-HIV-1 agents targeting HIV-1 capsid proteins RSC ADVANCES. 2023.01; 13 (3): 2156-2167. ( PubMed , DOI )

このページの先頭へ▲